Innovation in therapeutics has advanced at unprecedented levels. The successful development of novel medicines to treat significant unmet medical needs is driving keen corporate and investor engagement in the sector.

Investors and corporate clients value our unique insights and long-standing expertise in assessing the growth potential of innovative biopharma companies.

Digital Health & HealthTech resides at the intersection of healthcare and technology. Companies in this sector offer solutions to advance healthcare’s triple aim – improving clinical outcomes, optimizing costs and engaging the consumer.

We have a deep understanding of this growing sector and provide a uniquely tailored combination of strategic guidance, insights and capital that will enable Digital Health & HealthTech companies to address the unmet needs of our healthcare ecosystem.

Having experts in major sub-sectors and a culture that fosters cross-collaboration allows us to provide unrivaled insights to our clients who are navigating the rapidly evolving landscape.

The medical technology world's boundaries are increasingly blurred with those of other healthcare subsectors. Traditional single-use devices and capital equipment often incorporate sensor technology, digital solutions, mobile and home use, drug delivery, and/or complementary service models.

Our medical technology team works with emerging and established medical technology companies to be their trusted advisor and partner in mergers and acquisitions, capital raising and strategic collaborations.

The Diagnostics & Life Science Tools sector has seen a renaissance of late. In diagnostics, new technologies are transforming early detection and making prognosis/disease monitoring a critical element of patient care over time. In life science tools, there have been great advances from research to clinical and biopharma has never been more focused on outsourcing to the most trusted partners. Our diagnostics & life science tools team has strong domain expertise and partners with leading established and emerging companies as a trusted advisor across capital formation and M&A strategy.

Healthcare companies are always looking to utilize M&A as a means to drive shareholder value despite market cycles and uncertainties.

As our track record demonstrates, we partner with our clients to deliver deep sector insights and broad connectivity to provide trusted advice.

We partner with companies across the healthcare landscape to design and implement optimal capital structures that allow them to execute their business plans.

The capital formation process offers many different avenues for companies seeking to access leading investors and raise growth capital. Our team has significant domain expertise across the full spectrum of equity products including IPOs, Publicly & Confidentially Marketed Follow-on Offerings, Registered Directs, Direct Listings, Convertible Debt Offerings, At-the-Market (ATM) Transactions and SPACs.